Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Risk factors for non-alcoholic fatty liver disease-associated hepatic fibrosis in type 2 diabetes patients.

Mansour A, Mohajeri-Tehrani MR, Samadi M, Gerami H, Qorbani M, Bellissimo N, Poustchi H, Hekmatdoost A.

Acta Diabetol. 2019 Jun 13. doi: 10.1007/s00592-019-01374-x. [Epub ahead of print]

PMID:
31197470
2.

Cancer incidence in Iran in 2014: Results of the Iranian National Population-based Cancer Registry.

Roshandel G, Ghanbari-Motlagh A, Partovipour E, Salavati F, Hasanpour-Heidari S, Mohammadi G, Khoshaabi M, Sadjadi A, Davanlou M, Tavangar SM, Abadi H, Asgari A, Behrooz M, Cheraghi M, Danechin L, Dolatkhah R, Enferadi F, Esshaghi S, Farahani M, Farrokhzad S, Fateh M, Vahedi S, Golpazir A, Hasanzadeh M, Hazar N, Hoseini-Hoshyar H, Izadi M, Jafarnia A, Jahantigh M, Jalilvand A, Jazayeri M, Joola P, Kazemzadeh Y, Khalednejad M, Kooshki M, Madani A, Malekpour-Afshar R, Bayat AH, Moinfar Z, Mohamadifar H, Mohamadzadeh G, Motidost-Komleh R, Narooei M, Niksiar S, Pirnejad H, Poornajaf A, Pourshahi G, Rahnama A, Rashidpour B, Ravankhah Z, Rezaei K, Rezaeianzadeh A, Sadeghi G, Shahdadi A, Shahi M, Sharafi Z, Sharifi-Moghadam F, Soleimani A, Soltany-Hojatabad M, Tahmasebi Z, Yadolahi S, Yaghoubi-Ashrafi M, Zandian H, Zareiyan A, Poustchi H, Zendehdel K, Ostovar A, Janbabaei G, Reisi A, Malekzadeh R.

Cancer Epidemiol. 2019 May 24;61:50-58. doi: 10.1016/j.canep.2019.05.009. [Epub ahead of print]

PMID:
31132560
3.

Adherence to the Dietary Approaches to Stop Hypertension (DASH) diet and risk of total and cause-specific mortality: results from the Golestan Cohort Study.

Mokhtari Z, Sharafkhah M, Poustchi H, Sepanlou SG, Khoshnia M, Gharavi A, Sohrabpour AA, Sotoudeh M, Dawsey SM, Boffetta P, Abnet CC, Kamangar F, Etemadi A, Pourshams A, FazeltabarMalekshah A, Islami F, Brennan P, Malekzadeh R, Hekmatdoost A.

Int J Epidemiol. 2019 May 5. pii: dyz079. doi: 10.1093/ije/dyz079. [Epub ahead of print]

PMID:
31056682
4.

A prospective study of tea drinking temperature and risk of esophageal squamous cell carcinoma.

Islami F, Poustchi H, Pourshams A, Khoshnia M, Gharavi A, Kamangar F, Dawsey SM, Abnet CC, Brennan P, Sheikh M, Sotoudeh M, Nikmanesh A, Merat S, Etemadi A, Nasseri Moghaddam S, Pharoah PD, Ponder BA, Day NE, Jemal A, Boffetta P, Malekzadeh R.

Int J Cancer. 2019 Mar 20. doi: 10.1002/ijc.32220. [Epub ahead of print]

PMID:
30891750
5.

Association of Pro-inflammatory Dietary Intake and Non-Alcoholic Fatty Liver Disease: Findings from Iranian case-control study.

Vahid F, Shivappa N, Hekmatdoost A, R Hebert J, Poustchi H, Shamsipour A, Eslamparast T, Meibodi M, Rahmani D.

Int J Vitam Nutr Res. 2018 Jun;88(3-4):144-150. doi: 10.1024/0300-9831/a000571. Epub 2019 Mar 19.

PMID:
30887902
6.

The application of six dietary scores to a Middle Eastern population: a comparative analysis of mortality in a prospective study.

Hashemian M, Farvid MS, Poustchi H, Murphy G, Etemadi A, Hekmatdoost A, Kamangar F, Sheikh M, Pourshams A, Sepanlou SG, Fazeltabar Malekshah A, Khoshnia M, Gharavi A, Brennan PJ, Boffetta P, Dawsey SM, Reedy J, Subar AF, Abnet CC, Malekzadeh R.

Eur J Epidemiol. 2019 Apr;34(4):371-382. doi: 10.1007/s10654-019-00508-3. Epub 2019 Mar 18.

PMID:
30887377
7.

Flaxseed Supplementation Improves Anthropometric measurements, Metabolic, and Inflammatory Biomarkers in Overweight and Obese Adults.

Yari Z, Rahimlou M, Poustchi H, Hekmatdoost A.

Int J Vitam Nutr Res. 2019 Mar 7:1-8. doi: 10.1024/0300-9831/a000565. [Epub ahead of print]

PMID:
30843767
8.

Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting.

Sharafi H, Poustchi H, Azimian F, Tamadoni B, Ramezani R, Gouya MM, Sheikh M, Hashemi F, Tashakorian M, Alasvand R, Alavian SM, Merat S.

J Clin Virol. 2019 Apr;113:20-23. doi: 10.1016/j.jcv.2019.02.005. Epub 2019 Feb 25.

PMID:
30825832
9.

The PERSIAN Guilan Cohort Study (PGCS).

Mansour-Ghanaei F, Joukar F, Naghipour MR, Sepanlou SG, Poustchi H, Mojtahedi K, Balou HA, Heidarzadeh A, Malekzadeh R.

Arch Iran Med. 2019 Jan 1;22(1):39-45.

10.

Effects of Vitamin D Supplementation in Patients with Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Jalili M, Vahedi H, Poustchi H, Hekmatdoost A.

Int J Prev Med. 2019 Feb 12;10:16. doi: 10.4103/ijpvm.IJPVM_512_17. eCollection 2019.

11.

Environmental etiology of gastric cancer in Iran: a systematic review focusing on drinking water, soil, food, radiation, and geographical conditions.

Ghaffari HR, Yunesian M, Nabizadeh R, Nasseri S, Sadjadi A, Pourfarzi F, Poustchi H, Eshraghian A.

Environ Sci Pollut Res Int. 2019 Apr;26(11):10487-10495. doi: 10.1007/s11356-019-04493-8. Epub 2019 Feb 26.

PMID:
30806933
12.

Legume intake and risk of nonalcoholic fatty liver disease.

Bahrami A, Teymoori F, Eslamparast T, Sohrab G, Hejazi E, Poustchi H, Hekmatdoost A.

Indian J Gastroenterol. 2019 Feb;38(1):55-60. doi: 10.1007/s12664-019-00937-8. Epub 2019 Feb 22.

PMID:
30796701
13.

Urinary Biomarkers of Carcinogenic Exposure among Cigarette, Waterpipe, and Smokeless Tobacco Users and Never Users of Tobacco in the Golestan Cohort Study.

Etemadi A, Poustchi H, Chang CM, Blount BC, Calafat AM, Wang L, De Jesus VR, Pourshams A, Shakeri R, Shiels MS, Inoue-Choi M, Ambrose BK, Christensen CH, Wang B, Murphy G, Ye X, Bhandari D, Feng J, Xia B, Sosnoff CS, Kamangar F, Brennan P, Boffetta P, Dawsey SM, Abnet CC, Malekzadeh R, Freedman ND.

Cancer Epidemiol Biomarkers Prev. 2019 Feb;28(2):337-347. doi: 10.1158/1055-9965.EPI-18-0743. Epub 2019 Jan 8.

PMID:
30622099
14.

Individual and Combined Effects of Environmental Risk Factors for Esophageal Cancer Based on Results From theĀ Golestan Cohort Study.

Sheikh M, Poustchi H, Pourshams A, Etemadi A, Islami F, Khoshnia M, Gharavi A, Hashemian M, Roshandel G, Khademi H, Zahedi M, Abedi-Ardekani B, Boffetta P, Kamangar F, Dawsey SM, Pharaoh PD, Abnet CC, Day NE, Brennan P, Malekzadeh R.

Gastroenterology. 2019 Apr;156(5):1416-1427. doi: 10.1053/j.gastro.2018.12.024. Epub 2019 Jan 3.

PMID:
30611753
15.

The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease.

Saadati S, Hatami B, Yari Z, Shahrbaf MA, Eghtesad S, Mansour A, Poustchi H, Hedayati M, Aghajanpoor-Pasha M, Sadeghi A, Hekmatdoost A.

Eur J Clin Nutr. 2019 Mar;73(3):441-449. doi: 10.1038/s41430-018-0382-9. Epub 2019 Jan 4.

PMID:
30610213
16.

Cohort profile: The AZAR cohort, a health-oriented research model in areas of major environmental change in Central Asia.

Farhang S, Faramarzi E, Amini Sani N, Poustchi H, Ostadrahimi A, Alizadeh BZ, Somi MH.

Int J Epidemiol. 2018 Nov 14. doi: 10.1093/ije/dyy215. [Epub ahead of print] No abstract available.

PMID:
30445493
17.

Intra-familial Transmission of Chronic Hepatitis B Infection: A Large Population-Based Cohort Study in Northern Iran.

Katoonizadeh A, Motamed-Gorji N, Sharafkhah M, Ostovaneh M, Esmaili S, Eslami L, Gharravi A, Khoshnia M, Shayanrad A, Shakki Katouli F, Shiravi Khuzani A, Amini Kafi-Abad S, Maghsudlu M, George J, Poustchi H, Malekzadeh R.

Arch Iran Med. 2018 Oct 1;21(10):436-442.

18.

Point of Care Policy for Eliminating Hepatitis C, its Applicability and Acceptability.

Sheikh M, Poustchi H.

Arch Iran Med. 2018 Sep 1;21(9):425-427.

19.

Epidemiology of Head and Neck Cancers in Northern Iran: A 10-Year Trend Study From Golestan Province.

Taziki MH, Fazel A, Salamat F, Sedaghat SM, Ashaari M, Poustchi H, Shakeri R, Hoseinpoor R, Hasanpour-Heidari S, Roshandel G.

Arch Iran Med. 2018 Sep 1;21(9):406-411.

20.

Prevalence, Awareness, Treatment, Control, and Correlates of Hypertension in the Pars Cohort Study.

Gandomkar A, Poustchi H, Malekzadeh F, Malekzadeh MM, Moini M, Moghadami M, Imanieh H, Fattahi MR, Sagheb MM, Ayatollahi SMT, Sepanlou SG, Malekzadeh R.

Arch Iran Med. 2018 Aug 1;21(8):335-343.

21.

Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis.

Fadaei R, Poustchi H, Meshkani R, Moradi N, Golmohammadi T, Merat S.

Sci Rep. 2018 Aug 3;8(1):11691. doi: 10.1038/s41598-018-29639-5.

22.

Prevalence and Clinical Outcomes of Common Bile Duct Dilation in Patients Who Use Opium.

Radmard AR, Khorasanizadeh F, Poustchi H, Kooraki S, Mirminachi B, Sharafkhah M, Jafari E, Hashemi Taheri AP, Sotoudehmanesh R, Mohamadnejad M, Malekzadeh R, Merat S.

Am J Med Sci. 2018 Jul;356(1):39-46. doi: 10.1016/j.amjms.2018.04.003. Epub 2018 Apr 7.

PMID:
30049329
23.

Liver Transplantation Status in Iran: A Multi-center Report on the Main Transplant Indicators and Survival Rates.

Malek-Hosseini SA, Jafarian A, Nikeghbalian S, Poustchi H, Lankarani KB, Nasiri Toosi M, Salahi H, Dehghani M, Eshraghian A, Sharafkhah M, Eghtesad S, Motamed-Gorji N, Kazemi K, Salimi J, Moini M, Shamsaeefar A, Moini M, Dehghani M, B Khosravi M, Najafi A, Sattari H, Geramizadeh B, Shafiee M, Toutouni MN, Sanei B, Nejatollahi SM, Taghavi A, Bahador A, Aliakbarian M, Eghtesad B, Malekzadeh R.

Arch Iran Med. 2018 Jul 1;21(7):275-282.

24.

Causes of premature death and their associated risk factors in the Golestan Cohort Study, Iran.

Nalini M, Oranuba E, Poustchi H, Sepanlou SG, Pourshams A, Khoshnia M, Gharavi A, Dawsey SM, Abnet CC, Boffetta P, Brennan P, Sotoudeh M, Nikmanesh A, Merat S, Etemadi A, Shakeri R, Sohrabpour AA, Nasseri-Moghaddam S, Kamangar F, Malekzadeh R.

BMJ Open. 2018 Jul 18;8(7):e021479. doi: 10.1136/bmjopen-2018-021479.

25.

Prevalence of Chronic Constipation and Its Associated Factors in Pars Cohort Study: A Study of 9000 Adults in Southern Iran.

Moezi P, Salehi A, Molavi H, Poustchi H, Gandomkar A, Imanieh MH, Malekzadeh R.

Middle East J Dig Dis. 2018 Apr;10(2):75-83. doi: 10.15171/mejdd.2018.94. Epub 2018 Mar 15.

26.

Cardiovascular mortality in a Western Asian country: results from the Iran Cohort Consortium.

Fahimfar N, Khalili D, Sepanlou SG, Malekzadeh R, Azizi F, Mansournia MA, Roohafza H, Emamian MH, Hadaegh F, Poustchi H, Mansourian M, Hashemi H, Sharafkhah M, Pourshams A, Farzadfar F, Steyerberg EW, Fotouhi A.

BMJ Open. 2018 Jul 5;8(7):e020303. doi: 10.1136/bmjopen-2017-020303.

27.

Nut consumption and the risk of oesophageal squamous cell carcinoma in the Golestan Cohort Study.

Hashemian M, Murphy G, Etemadi A, Poustchi H, Sharafkhah M, Kamangar F, Pourshams A, Malekshah AF, Khoshnia M, Gharavi A, Hekmatdoost A, Brennan PJ, Boffetta P, Dawsey SM, Abnet CC, Malekzadeh R.

Br J Cancer. 2018 Jul;119(2):176-181. doi: 10.1038/s41416-018-0148-0. Epub 2018 Jun 28.

PMID:
29950612
28.

The protocol of a population-based prospective cohort study in southwest of Iran to analyze common non-communicable diseases: Shahrekord cohort study.

Khaledifar A, Hashemzadeh M, Solati K, Poustchi H, Bollati V, Ahmadi A, Kheiri S, Samani KG, Banitalebi M, Sedehi M, Malekzadeh R.

BMC Public Health. 2018 May 25;18(1):660. doi: 10.1186/s12889-018-5364-2.

29.

Drug Use for Secondary Prevention of Cardiovascular Diseases in Golestan, Iran: Results From the Golestan Cohort Study.

Nalini M, Sepanlou SG, Pourshams A, Poustchi H, Sharafkhah M, Bahrami H, Kamangar F, Malekzadeh R.

Arch Iran Med. 2018 Mar 1;21(3):86-94.

30.

Significant SNPs Related to Telomere Length and Hepatocellular Carcinoma Risk in Chronic Hepatitis B Carriers

Mohamadkhani A, Pourasgari M, Poustchi H.

Asian Pac J Cancer Prev. 2018 Mar 27;19(3):585-590. Review.

31.

The PERSIAN Cohort: Providing the Evidence Needed for Healthcare Reform.

Eghtesad S, Mohammadi Z, Shayanrad A, Faramarzi E, Joukar F, Hamzeh B, Farjam M, Zare Sakhvidi MJ, Miri-Monjar M, Moosazadeh M, Hakimi H, Rahimi Kazerooni S, Cheraghian B, Ahmadi A, Nejatizadeh A, Mohebbi I, Pourfarzi F, Roozafzai F, Motamed-Gorji N, Montazeri SA, Masoudi S, Amin-Esmaeili M, Danaie N, Mirhafez SR, Hashemi H, Poustchi H, Malekzadeh R.

Arch Iran Med. 2017 Nov 1;20(11):691-695.

32.

Association of carotid intima media thickness with atherogenic index of plasma, apo B/apo A-I ratio and paraoxonase activity in patients with non-alcoholic fatty liver disease.

Fadaei R, Meshkani R, Poustchi H, Fallah S, Moradi N, Panahi G, Merat S, Golmohammadi T.

Arch Physiol Biochem. 2019 Feb;125(1):19-24. doi: 10.1080/13813455.2018.1429475. Epub 2018 Jan 23.

PMID:
29359590
33.

Building cancer registries in a lower resource setting: The 10-year experience of Golestan, Northern Iran.

Roshandel G, Semnani S, Fazel A, Honarvar M, Taziki M, Sedaghat S, Abdolahi N, Ashaari M, Poorabbasi M, Hasanpour S, Hosseini S, Mansuri S, Jahangirrad A, Besharat S, Moghaddami A, Mirkarimi H, Salamat F, Ghasemi-Kebria F, Jafari N, Shokoohifar N, Gholami M, Sadjadi A, Poustchi H, Bray F, Malekzadeh R.

Cancer Epidemiol. 2018 Feb;52:128-133. doi: 10.1016/j.canep.2017.12.014. Epub 2018 Jan 4.

PMID:
29306787
34.

Opium Use and Risk of Pancreatic Cancer: A Prospective Cohort Study.

Moossavi S, Mohamadnejad M, Pourshams A, Poustchi H, Islami F, Sharafkhah M, Mirminachi B, Nasseri-Moghaddam S, Semnani S, Shakeri R, Etemadi A, Merat S, Khoshnia M, Dawsey SM, Pharoah PD, Brennan P, Abnet CC, Boffetta P, Kamangar F, Malekzadeh R.

Cancer Epidemiol Biomarkers Prev. 2018 Mar;27(3):268-273. doi: 10.1158/1055-9965.EPI-17-0592. Epub 2017 Dec 20.

35.

Prospective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): Rationale, Objectives, and Design.

Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar AA, Hekmatdoost A, Mohammadi Z, Mahmoudi Z, Shayanrad A, Roozafzai F, Sheikh M, Jalaeikhoo A, Somi MH, Mansour-Ghanaei F, Najafi F, Bahramali E, Mehrparvar A, Ansari-Moghaddam A, Enayati AA, Esmaeili Nadimi A, Rezaianzadeh A, Saki N, Alipour F, Kelishadi R, Rahimi-Movaghar A, Aminisani N, Boffetta P, Malekzadeh R.

Am J Epidemiol. 2018 Apr 1;187(4):647-655. doi: 10.1093/aje/kwx314.

36.

Toenail mineral concentration and risk of esophageal squamous cell carcinoma, results from the Golestan Cohort Study.

Hashemian M, Murphy G, Etemadi A, Poustchi H, Brockman JD, Kamangar F, Pourshams A, Khoshnia M, Gharavi A, Dawsey SM, Brennan PJ, Boffetta P, Hekmatdoost A, Malekzadeh R, Abnet CC.

Cancer Med. 2017 Dec;6(12):3052-3059. doi: 10.1002/cam4.1247. Epub 2017 Nov 10.

37.

The association between waterpipe smoking and gastroesophageal reflux disease.

Etemadi A, Gandomkar A, Freedman ND, Moghadami M, Fattahi MR, Poustchi H, Islami F, Boffetta P, Dawsey SM, Abnet CC, Malekzadeh R.

Int J Epidemiol. 2017 Dec 1;46(6):1968-1977. doi: 10.1093/ije/dyx158.

38.

Prevalence and Correlates of Gastroesophageal Reflux Disease in Southern Iran: Pars Cohort Study.

Khodamoradi Z, Gandomkar A, Poustchi H, Salehi A, Imanieh MH, Etemadi A, Malekzadeh R.

Middle East J Dig Dis. 2017 Jul;9(3):129-138. doi: 10.15171/mejdd.2017.63.

39.

The Prevalence of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus in an Iranian Population.

Rabiee B, Roozafzai F, Hemasi GR, Poustchi H, Keyvani H, Khonsari MR, Ajdarkosh H, Maadi M, Sima Saeedian F, Zamani F.

Middle East J Dig Dis. 2017 Apr;9(2):86-93. doi: 10.15171/mejdd.2017.56.

40.

Multimorbidity as an important issue among women: results of a gender difference investigation in a large population-based cross-sectional study in West Asia.

Alimohammadian M, Majidi A, Yaseri M, Ahmadi B, Islami F, Derakhshan M, Delavari A, Amani M, Feyz-Sani A, Poustchi H, Pourshams A, Sadjadi AM, Khoshnia M, Qaravi S, Abnet CC, Dawsey S, Brennan P, Kamangar F, Boffetta P, Sadjadi A, Malekzadeh R.

BMJ Open. 2017 May 9;7(5):e013548. doi: 10.1136/bmjopen-2016-013548.

41.

Prevalence and determinants of chronic kidney disease in northeast of Iran: Results of the Golestan cohort study.

Sepanlou SG, Barahimi H, Najafi I, Kamangar F, Poustchi H, Shakeri R, Hakemi MS, Pourshams A, Khoshnia M, Gharravi A, Broumand B, Nobakht-Haghighi A, Kalantar-Zadeh K, Malekzadeh R.

PLoS One. 2017 May 3;12(5):e0176540. doi: 10.1371/journal.pone.0176540. eCollection 2017.

42.

Oral health and mortality in the Golestan Cohort Study.

Vogtmann E, Etemadi A, Kamangar F, Islami F, Roshandel G, Poustchi H, Pourshams A, Khoshnia M, Gharravi A, Brennan PJ, Boffetta P, Dawsey SM, Malekzadeh R, Abnet CC.

Int J Epidemiol. 2017 Dec 1;46(6):2028-2035. doi: 10.1093/ije/dyx056.

43.

Egg consumption and risk of non-alcoholic fatty liver disease.

Mokhtari Z, Poustchi H, Eslamparast T, Hekmatdoost A.

World J Hepatol. 2017 Apr 8;9(10):503-509. doi: 10.4254/wjh.v9.i10.503.

44.

Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study.

Naderian M, Kolahdoozan S, Sharifi AS, Garmaroudi G, Yaseri M, Poustchi H, Sohrabpour AA.

Arch Iran Med. 2017 Apr;20(4):211-217. doi: 0172004/AIM.005.

45.

Epidemiologic Study of Opium Use in Pars Cohort Study: A Study of 9000 Adults in a Rural Southern Area of Iran.

Fallahzadeh MA, Salehi A, Naghshvarian M, Fallahzadeh MH, Poustchi H, Sepanlou SG, Gandomkar A, Malekzadeh R.

Arch Iran Med. 2017 Apr;20(4):205-210. doi: 0172004/AIM.004.

46.

Lower circulating irisin is associated with nonalcoholic fatty liver disease and type 2 diabetes.

Shanaki M, Moradi N, Emamgholipour S, Fadaei R, Poustchi H.

Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S467-S472. doi: 10.1016/j.dsx.2017.03.037. Epub 2017 Mar 31.

PMID:
28392354
47.

Dairy Food Intake and All-Cause, Cardiovascular Disease, and Cancer Mortality: The Golestan Cohort Study.

Farvid MS, Malekshah AF, Pourshams A, Poustchi H, Sepanlou SG, Sharafkhah M, Khoshnia M, Farvid M, Abnet CC, Kamangar F, Dawsey SM, Brennan P, Pharoah PD, Boffetta P, Willett WC, Malekzadeh R.

Am J Epidemiol. 2017 Apr 15;185(8):697-711. doi: 10.1093/aje/kww139.

48.

Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial.

Mofidi F, Poustchi H, Yari Z, Nourinayyer B, Merat S, Sharafkhah M, Malekzadeh R, Hekmatdoost A.

Br J Nutr. 2017 Mar;117(5):662-668. doi: 10.1017/S0007114517000204. Epub 2017 Mar 27.

PMID:
28345499
49.

White rice intake and incidence of type-2 diabetes: analysis of two prospective cohort studies from Iran.

Golozar A, Khalili D, Etemadi A, Poustchi H, Fazeltabar A, Hosseini F, Kamangar F, Khoshnia M, Islami F, Hadaegh F, Brennan P, Boffetta P, Abnet CC, Dawsey SM, Azizi F, Malekzadeh R, Danaei G.

BMC Public Health. 2017 Jan 31;17(1):133. doi: 10.1186/s12889-016-3999-4.

50.

The Presence of Autoantibodies to Cytoplasmic Rod and Ring Particles in the Serum of Patients with Chronic Hepatitis C Virus Infection.

Afsharzadeh F, Bokharaei-Salim F, Esghaei M, Monavari SH, Merat S, Poustchi H, Haj-Sheykholeslami A, Keyvani H.

Hepat Mon. 2016 Dec 11;16(12):e42388. doi: 10.5812/hepatmon.42388. eCollection 2016 Dec.

Supplemental Content

Loading ...
Support Center